Literature DB >> 26514527

Lung Cancer in a Rural Area of China: Rapid Rise in Incidence and Poor Improvement in Survival.

Juan Yang1, Jian Zhu, Yong-Hui Zhang, Yong-Sheng Chen, Lu-Lu Ding, Thomas W Kensler, Jian-Guo Chen.   

Abstract

BACKGROUND: Lung cancer has been a major health problem in developed countries for several decades, and has emerged recently as the leading cause of cancer death in many developing countries. The incidence of lung cancer appears to be increasing more rapidly in rural than in urban areas of China. This paper presents the trends of lung cancer incidence and survival derived from a 40-year population-based cancer monitoring program in a rural area, Qidong, China.
MATERIALS AND METHODS: The Qidong cancer registration data of 1972- 2011 were used to calculate the crude rate, age-standardized rate by Chinese population (CASR) and by world population (WASR), birth cohort rates, and other descriptive features. Active and passive methods were used to construct the data set, with a deadline of the latest follow-up of April 30, 2012.
RESULTS: The total number of lung cancer cases was 15,340, accounting for 16.5% of all sites combined. The crude incidence rate, CASR and WASR of this cancer were 34.1, 15.7 and 25.4 per 100,000, respectively. Males had higher crude rates than females (49.7 vs 19.0). Rapidly increasing trends were found in annual percent change resulting in lung cancer being a number one cancer site after year 2010 in Qidong. Birth cohort analysis showed incidence rates have increased for all age groups over 24 years old. The 5 year observed survival rates were 3.55% in 1973-1977, 3.92 in 1983-1987, 3.69% in 1993-1997, and 6.32% in 2003-2007. Males experienced poorer survival than did females.
CONCLUSIONS: Lung cancer has become a major cancer-related health problem in this rural area. The rapid increases in incidence likely result from an increased cigarette smoking rate and evolving environmental risk factors. Lung cancer survival, while showing some improvement in prognosis, still remains well below that observed in the developed areas of the world.

Entities:  

Mesh:

Year:  2015        PMID: 26514527     DOI: 10.7314/apjcp.2015.16.16.7295

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  10 in total

1.  Manipulations in HIWI level exerts influence on the proliferation of human non-small cell lung cancer cells.

Authors:  Yuguang Wang; Jia Liu; Guangyao Wu; Fang Yang
Journal:  Exp Ther Med       Date:  2016-02-24       Impact factor: 2.447

2.  Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.

Authors:  Xin Wang; Xiuyi Zhi; Yi Zhang; Guangyu An; Guosheng Feng
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Silk fibroin peptide suppresses proliferation and induces apoptosis and cell cycle arrest in human lung cancer cells.

Authors:  Mei-Sa Wang; Yi-Bo Du; Hui-Ming Huang; Zhong-Ling Zhu; Shuang-Shuang Du; Shao-Yong Chen; Hong-Ping Zhao; Zhao Yan
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

4.  Coping with stigma: the experiences of Chinese patients living with lung cancer.

Authors:  Huaxia Liu; Qianqian Yang; Georgia L Narsavage; Chunling Yang; Yue Chen; Guiying Xu; Xia Wu
Journal:  Springerplus       Date:  2016-10-13

5.  MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer.

Authors:  Jing-Hua Li; Shan-Shan Sun; Ning Li; Peng Lv; Shu-Yang Xie; Ping-Yu Wang
Journal:  Oncotarget       Date:  2017-08-14

6.  Effect of etoposide-induced alteration of the Mdm2-Rb signaling pathway on cellular senescence in A549 lung adenocarcinoma cells.

Authors:  Wenjing Dai; Yi Jiang; Kairong Chen; Jing Qiu; Jian Sun; Wei Zhang; Xiafei Zhou; Na Huang; Yunhui Li; Wancheng Li
Journal:  Oncol Lett       Date:  2017-07-27       Impact factor: 2.967

7.  Diagnostic Value of Plasma MicroRNAs for Lung Cancer Using Support Vector Machine Model.

Authors:  Wei Wang; Mingcui Ding; Xiaoran Duan; Xiaolei Feng; Pengpeng Wang; Qingfeng Jiang; Zhe Cheng; Wenjuan Zhang; Songcheng Yu; Wu Yao; Liuxin Cui; Yongjun Wu; Feifei Feng; Yongli Yang
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.478

8.  Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?

Authors:  Wenlong Zheng; Hui Zhang; Chengfeng Shen; Shuang Zhang; Dezheng Wang; Wei Li; Guohong Jiang
Journal:  Thorac Cancer       Date:  2020-03-03       Impact factor: 3.500

9.  Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC.

Authors:  Juan Zhou; Suqin Ben; Tan Xu; Liqin Xu; Xin Yao
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

10.  Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.

Authors:  Xin Wang; Yi Zhang; Xiuyi Zhi
Journal:  Thorac Cancer       Date:  2017-07-20       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.